I know one medical device company with one small clinical trial and their OS is ~151M. IPIX has eight clinical trials, five of them being Phase 2, and their OS is ~138M. Both companies have similar MC. Here're the trial timelines to date.
Most here think that IPIX can issue 75 million dollars worth of shares into the market with no consequences. I believe a R/S would occur if that much dilution happens. That is why I am hopefully anticipating a partnership. I have no other issues with the company and leo has done a great job up to now. He now needs to finish the job and nail down a financal partnership. IPIX DRUGS MATTER
Simply not true. If the stock was 3.00 right now it would still be undervalued from a valuation standpoint. A deal and the stock goes to 10. The O/S is not even close to being tpo high.